AXSOME THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
AXSOME THERAPEUTICS, INC. (AXSM) reported Basic Shares Outstanding (Weighted Average) of 51.80 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 51.80M shares, a 4.77% increase year-over-year.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 51.20M shares, a 4.76% increase year-over-year.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 50.64M shares, a 4.31% increase year-over-year.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 50.02M shares, a 3.91% increase year-over-year.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 49.75M shares, a 3.83% increase from fiscal 2024.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 47.91M shares, a 5.48% increase from fiscal 2023.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 45.43M shares, a 11.73% increase from fiscal 2022.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 40.66M shares, a 8.07% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 51.80M shares 10-Q · filed 2026-08-10 | 51.50M shares 10-Q · filed 2026-08-10 | 51.21M shares derived: average of 3 quarters · filed 2026-08-10 | 50.92M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 51.20M shares 10-Q · filed 2026-05-04 | 50.92M shares derived: average of 2 quarters · filed 2026-05-04 | 50.62M shares derived: average of 3 quarters · filed 2026-05-04 | 50.33M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | 50.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | 50.33M shares derived: average of 2 quarters · filed 2026-02-23 | 50.03M shares derived: average of 3 quarters · filed 2026-08-10 | 49.75M shares 10-K · filed 2026-02-23 |
| 2025-09-30 | 50.02M shares 10-Q · filed 2025-11-03 | 49.73M shares derived: average of 2 quarters · filed 2026-08-10 | 49.45M shares 10-Q · filed 2025-11-03 | 49.22M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | 49.44M shares 10-Q · filed 2026-08-10 | 49.16M shares 10-Q · filed 2026-08-10 | 48.95M shares derived: average of 3 quarters · filed 2026-08-10 | 48.75M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | 48.87M shares 10-Q · filed 2026-05-04 | 48.71M shares derived: average of 2 quarters · filed 2026-05-04 | 48.52M shares derived: average of 3 quarters · filed 2026-05-04 | 48.28M shares derived: average of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | 48.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | 48.34M shares derived: average of 2 quarters · filed 2026-02-23 | 48.09M shares derived: average of 3 quarters · filed 2026-02-23 | 47.91M shares 10-K · filed 2026-02-23 |
| 2024-09-30 | 48.14M shares 10-Q · filed 2025-11-03 | 47.86M shares derived: average of 2 quarters · filed 2025-11-03 | 47.70M shares 10-Q · filed 2025-11-03 | 47.61M shares derived: average of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | 47.57M shares 10-Q · filed 2025-08-04 | 47.48M shares 10-Q · filed 2025-08-04 | 47.44M shares derived: average of 3 quarters · filed 2026-02-23 | 47.36M shares derived: average of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | 47.39M shares 10-Q · filed 2025-05-05 | 47.37M shares derived: average of 2 quarters · filed 2026-02-23 | 47.29M shares derived: average of 3 quarters · filed 2026-02-23 | 46.38M shares derived: average of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | 47.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | 47.23M shares derived: average of 2 quarters · filed 2026-02-23 | 46.05M shares derived: average of 3 quarters · filed 2026-02-23 | 45.43M shares 10-K · filed 2026-02-23 |
| 2023-09-30 | 47.12M shares 10-Q · filed 2024-11-12 | 45.39M shares derived: average of 2 quarters · filed 2024-11-12 | 44.78M shares 10-Q · filed 2024-11-12 | 44.45M shares derived: average of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | 43.67M shares 10-Q · filed 2024-08-05 | 43.60M shares 10-Q · filed 2024-08-05 | 43.56M shares derived: average of 3 quarters · filed 2025-02-18 | 43.09M shares derived: average of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | 43.52M shares 10-Q · filed 2024-05-06 | 43.50M shares derived: average of 2 quarters · filed 2025-02-18 | 42.90M shares derived: average of 3 quarters · filed 2025-02-18 | 41.95M shares derived: average of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | 43.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | 42.59M shares derived: average of 2 quarters · filed 2025-02-18 | 41.42M shares derived: average of 3 quarters · filed 2025-02-18 | 40.66M shares 10-K · filed 2025-02-18 |
| 2022-09-30 | 41.70M shares 10-Q · filed 2023-11-06 | 40.39M shares derived: average of 2 quarters · filed 2023-11-06 | 39.72M shares 10-Q · filed 2023-11-06 | 39.22M shares derived: average of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | 39.08M shares 10-Q · filed 2023-08-07 | 38.70M shares 10-Q · filed 2023-08-07 | 38.39M shares derived: average of 3 quarters · filed 2024-02-23 | 38.21M shares derived: average of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | 38.32M shares 10-Q · filed 2023-05-09 | 38.04M shares derived: average of 2 quarters · filed 2024-02-23 | 37.92M shares derived: average of 3 quarters · filed 2024-02-23 | 37.84M shares derived: average of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | 37.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | 37.72M shares derived: average of 2 quarters · filed 2024-02-23 | 37.68M shares derived: average of 3 quarters · filed 2024-02-23 | 37.62M shares 10-K · filed 2024-02-23 |
| 2021-09-30 | 37.68M shares 10-Q · filed 2022-11-07 | 37.64M shares derived: average of 2 quarters · filed 2022-11-07 | 37.57M shares 10-Q · filed 2022-11-07 | |
| 2021-06-30 | 37.60M shares 10-Q · filed 2022-08-09 | 37.51M shares 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | 37.21M shares 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |